DK1448772T3 - Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor - Google Patents

Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor

Info

Publication number
DK1448772T3
DK1448772T3 DK02777356T DK02777356T DK1448772T3 DK 1448772 T3 DK1448772 T3 DK 1448772T3 DK 02777356 T DK02777356 T DK 02777356T DK 02777356 T DK02777356 T DK 02777356T DK 1448772 T3 DK1448772 T3 DK 1448772T3
Authority
DK
Denmark
Prior art keywords
methods
amino acid
expression levels
proline
tnf receptor
Prior art date
Application number
DK02777356T
Other languages
Danish (da)
English (en)
Inventor
William Brondyk
Xuliang Jiang
Rene Lynn Schweickhardt
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of DK1448772T3 publication Critical patent/DK1448772T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DK02777356T 2001-11-30 2002-11-21 Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor DK1448772T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34064801P 2001-11-30 2001-11-30
PCT/EP2002/013059 WO2003046160A2 (fr) 2001-11-30 2002-11-21 Procedes pour augmenter les niveaux d'expression de proteines

Publications (1)

Publication Number Publication Date
DK1448772T3 true DK1448772T3 (da) 2007-11-19

Family

ID=23334343

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02777356T DK1448772T3 (da) 2001-11-30 2002-11-21 Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor

Country Status (12)

Country Link
US (2) US7258997B2 (fr)
EP (1) EP1448772B1 (fr)
JP (1) JP2005535281A (fr)
AT (1) ATE367438T1 (fr)
AU (1) AU2002338947B2 (fr)
CA (1) CA2466298A1 (fr)
DE (1) DE60221273D1 (fr)
DK (1) DK1448772T3 (fr)
ES (1) ES2290337T3 (fr)
IL (1) IL162133A0 (fr)
PT (1) PT1448772E (fr)
WO (1) WO2003046160A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258997B2 (en) * 2001-11-30 2007-08-21 Applied Research Systems Ars Holding N.V. Methods of increasing protein expression levels
CA2548940A1 (fr) * 2003-12-23 2005-07-14 Applied Research Systems Ars Holding N.V. Procede de production de proteines de liaison au facteur de necrose tumorale
US8722348B2 (en) * 2008-05-28 2014-05-13 Wayne State University Method and composition for a protein transduction technology and its applications
PT2705143T (pt) 2011-05-02 2021-04-07 Univ Wayne State Tecnologia de células pluripotentes induzidas por proteínas e utilizações da mesma
DK3060237T3 (da) 2013-10-25 2021-10-25 Univ Wayne State Modificeret omprogrammeringsprotein til anvendelse i behandling af cancer
AU2020297594A1 (en) * 2019-06-21 2022-02-03 Kernal Biologics, Inc. Engineered oncoselective protein expression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393438B1 (fr) 1989-04-21 2005-02-16 Amgen Inc. Récepteur du TNF, protéine liant le TNF at ADN codant pour ceux-ci
CA2122923C (fr) * 1991-11-25 1999-01-19 Roy L. Blank Compositions pour lutter contre les rides de la peau et/ou l'atrophie cutanee
IL107268A0 (en) * 1993-10-12 1994-01-25 Yeda Res & Dev Molecules influencing the shedding of the tnf receptor, their preparation and their use
US7074901B2 (en) * 2001-05-25 2006-07-11 Serono Genetics Institute S.A. Isolated human vCOL16A1 polypeptide and fragments thereof
US7258997B2 (en) * 2001-11-30 2007-08-21 Applied Research Systems Ars Holding N.V. Methods of increasing protein expression levels

Also Published As

Publication number Publication date
US7258997B2 (en) 2007-08-21
EP1448772B1 (fr) 2007-07-18
ES2290337T3 (es) 2008-02-16
DE60221273D1 (de) 2007-08-30
AU2002338947B2 (en) 2007-09-13
WO2003046160A2 (fr) 2003-06-05
CA2466298A1 (fr) 2003-06-05
JP2005535281A (ja) 2005-11-24
US20050074840A1 (en) 2005-04-07
US20080014635A1 (en) 2008-01-17
IL162133A0 (en) 2005-11-20
PT1448772E (pt) 2007-10-02
ATE367438T1 (de) 2007-08-15
WO2003046160A3 (fr) 2003-07-31
EP1448772A2 (fr) 2004-08-25
AU2002338947A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
ATE417595T1 (de) Keratin-bindende polypeptide
EP1767546A4 (fr) Proteine chimerique inhibitrice d'angiogenese et utilisation associee
PE20061115A1 (es) Anticuerpos anti-il-12, epitopos, composiciones, metodos y usos
IL142103A0 (en) Receptor based antagonists and methods of making and using
CO5690612A2 (es) Mimeticuerpos humanos centrales de la region de bisagra, mimeticos de la eritropoyetina, composiciones, metodos y usos
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
ATE533845T1 (de) Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken
ATE551048T1 (de) Proteinhydrolysate enthaltende kosmetische zusammensetzungen
IL171356A (en) Anti-interferon receptor antibody for treatment of inflammatory bowel disease
DE60335216D1 (de) Adiponektin-rezeptor und dafür kodierendes gen
EA200700973A1 (ru) Слитый белок, содержащий домен bh3 белка «вh3-только»
DK1383874T3 (da) Varianter af lipogygenase og deres anvendelse
DK1448772T3 (da) Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor
DE60118359D1 (de) Humanische pellino-polypeptide
WO2003012053A8 (fr) Identification du recepteur et des sites de liaison de l'heparine dans fgf4 par mutagenese basee sur une structure
WO2000058465A3 (fr) Analogues polypeptidiques de flint
NO20025152D0 (no) EDG8-reseptor, dens fremstilling og anvendelse
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
JP2005535281A5 (fr)
RU2011114984A (ru) Мутантный пестивирус с мутациями в гене core и области ns3
EA200400894A1 (ru) Мутантные ifnar2, их получение и применение
ATE358682T1 (de) Klonierte rezeptoren des glukagon-ähnlichen peptids-2
DE602004030899D1 (de) Neues screening-verfahren
IL175019A0 (en) Cxcl8 antagonists, their preparation and use
DK1614690T3 (da) Peptidfragment af LYVE-1 og antistof mod dette